OVA-Q4 Peptide, pQ4, SIIQFEKL, OVA (257-264) Variant contains a glutamine at position 4, altering charge and hydrogen-bonding capabilities within the epitope. Its sequence supports studies of MHC pocket adaptation and TCR contact surfaces. Researchers employ it to assess structural tolerance to mid-core substitutions. The peptide aids nuanced exploration of OVA variant antigenicity.
CAT No: O05021
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More